SG
ELGX

Societe Generale’s Endologix Inc ELGX Stock Holding History

Societe Generale’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$1.1M Buy
+8,813
New +$1.01M 0.01% 1233

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Societe Generale's ELGX Position: Q2 2016 in Review

Societe Generale opened a new position in Endologix Inc (ELGX) in Q2 2016: 8,813 shares worth $1.1M. The stake represents 0.01% of the portfolio and ranks #1233 among its holdings.

163 funds tracked by Wall St. Rank hold ELGX as of Q2 2016.

  • Societe Generale held 8,813 shares of Endologix Inc worth $1.1M as of Q2 2016.
  • Endologix Inc was a new Societe Generale position in Q2 2016.
  • Endologix Inc made up 0.01% of Societe Generale's portfolio in Q2 2016, its #1233 holding.
  • 163 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.